Cite
HARVARD Citation
Rosenbloom, M. et al. (n.d.). A phase II, single center, randomized, double‐blind, placebo‐controlled study of the safety and therapeutic effectiveness of intranasal glulisine in amnestic mild cognitive impairment and probable mild Alzheimer's disease. Alzheimer's & dementia. p. n/a. [Online].